Company news
Apyx Medical Corporation news in 2022
Apyx Medical Corporation's news releases, calls and decks from 2022, newest first.
Apyx Medical Corporation Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook
November 9, 2022
Apyx Medical Corporation Reports Second Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook
August 10, 2022
Apyx Medical Corporation Releases Environmental, Social and Governance Data in New Tear Sheet
July 26, 2022
Renuvion® cleared by FDA for neck laxity procedures offering patients a minimally invasive option to eliminate sagging neck
July 17, 2022
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® to Improve Appearance of Lax (Loose) Skin
July 17, 2022
Apyx Medical Corporation Announces Results of the U.S. IDE Clinical Study Evaluating the Use of Renuvion to Improve the Appearance of Lax Skin in the Neck and Submental Region
July 7, 2022
Renuvion® dermal handpiece for wrinkle-reduction procedures cleared by FDA
June 27, 2022
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® Cosmetic Technology in Dermal Resurfacing Procedures
May 25, 2022
Apyx Medical Corporation Reports First Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook
May 11, 2022
Apyx Medical Corporation Announces FDA 510(k) Submission with Clinical Study Support for the Use of the Renuvion® APR Handpiece for Aesthetic Procedures to Improve Appearance of Lax Skin
April 3, 2022
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Outlook
March 16, 2022
Apyx Medical Corporation Announces Peer-Reviewed Publication Featuring Results from the U.S. IDE Clinical Study Evaluating the Renuvion® Dermal Handpiece Using Apyx’s Helium Plasma Technology for Dermal Resurfacing Procedures
February 16, 2022
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2021 Revenue Results
January 9, 2022